Froggy, did you have that on delayed send? Old fake news.
Chinese "Devil Virus" - anyone worried?
- Thread starter manwithnoname
- Start date
- Latest activity Latest activity:
The value of their donation to the Conservative Party?
Really haha - just came up on Newsnow. Strange ! Though unusually prescient 😉
Dunk used to get caught it a few times with that too.. with his 'insider' knowledge
Thought it was a bit risky giving it to a 90 year old in case she drops dead of natural causes.
Although that could be the idea....
*straps tin foil hat on tighter*
FWIW, having done a fair bit of reading on mrna (at a basic level obv, I'm not a fucking scientist or even a science geek), it's hard to see any major issues arising aside for possibly those with undiagnosed autoimmune problems, & they would suffer the same problems if they had contracted the virus anyway.
It's hard to know what's the truth anymore, and tbh, I avoid all news and media, but is it true this "vaccine" doesn't actually stop you from catching the virus or spreading it? Rather it just stops you from getting ill?
Doesn't really seem like a vaccine to me in the traditional sense.
Doesn't really seem like a vaccine to me in the traditional sense.
That's how all vaccines work.
They basically train your immune system to fight it off like it does a myriad of other things every day.
But cos it fights it off (basically kills it) so quickly the chances of spreading it whilst it's being killed are small.
Very interesting numbers I just saw on the news in Japan regarding the flu.
The left column is the week, starting at week 43.
All the figures under the year are for those that have contracted the flu. Look at 2020.
Obviously, having only the bare minimum international travel will be a big factor, but you have to say that 99.9% of people wearing masks, disinfecting their hands, going out less (people still do go out here as government can't enforce people to stay home) and generally being more careful have shown a drastic effect on flu infection. Crazy.
The left column is the week, starting at week 43.
All the figures under the year are for those that have contracted the flu. Look at 2020.
Obviously, having only the bare minimum international travel will be a big factor, but you have to say that 99.9% of people wearing masks, disinfecting their hands, going out less (people still do go out here as government can't enforce people to stay home) and generally being more careful have shown a drastic effect on flu infection. Crazy.
My extremely basic and rudimentary understanding of vaccines is that they inject you with dead cells of the virus and your body develops the antibodies to deal with the real thing when it comes along.
This vaccine doesn't appear to be doing that, just rather masking symptoms. Unless I'm mistaken?
I think my dad has a cousin called Margaret Keenan. If she's anything like the women on my dad's side of the family then she'll be a fucking rocket and no one will know if she has the autism or not.
There are multiple types of vaccines and ways for vaccines to act on the body - the last I saw re. Covid vaccines was about 9 different forms.
It seems 5 methods under development for Covid (and 78 companies working on them) :
https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
Second correction, this chart says 10 methods of development :
Last edited:
This one is easier to read :
https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker
https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker
Here's one of the best basic explanations:
COVID-19 mRNA vaccines give instructions for our cells to make a harmless piece of what is called the “spike protein.” The spike protein is found on the surface of the virus that causes COVID-19.
COVID-19 mRNA vaccines are given in the upper arm muscle. Once the instructions (mRNA) are inside the muscle cells, the cells use them to make the protein piece. After the protein piece is made, the cell breaks down the instructions and gets rid of them.
Next, the cell displays the protein piece on its surface. Our immune systems recognize that the protein doesn’t belong there and begin building an immune response and making antibodies, like what happens in natural infection against COVID-19.
At the end of the process, our bodies have learned how to protect against future infection. The benefit of mRNA vaccines, like all vaccines, is those vaccinated gain this protection without ever having to risk the serious consequences of getting sick with COVID-19.
So, is this going to be like a flu jab thing with different vaccines every year?
To determine this would require a detailed understanding of the virus and its genetics, as well as the pre-clinical research undertaken on the vaccine at a biochemistry level. I would advise you to just listen to the medical advice being relayed to you by the government, and follow it.
Did they fail in human trials?
Have they completed the trials ?
Yep. The Border Collies won again.
Not true. They merely substituted them for microdosing. I for one feel better knowing the vaccine was not studied in a totally different species, but rather in African and/or Indian villagers who consent with thumb prints.
https://www.researchgate.net/public..._Safer_clinical_trials_and_fewer_animal_tests
Swiss stake slower, more cautious Covid vaccine path
Issued on: 07/12/2020 - 14:48
Prudence in the Swiss context is justified, says Siegrist Fabrice COFFRINI AFP
4 min
ADVERTISING
Geneva (AFP)
While other countries gear up for rapid roll-outs of Covid-19 vaccines, Switzerland is staking out a slower path, prizing caution over speed, according to a leading vaccine expert.
Britain and Russia will both begin mass vaccination this week, while US and European regulators are expected to provide emergency approval for two vaccines very shortly, with millions of doses set to be given by the end of the year.
But in Switzerland, authorities are in no hurry to approve a vaccine. The first few doses not expected to arrive before late January and larger volumes several months after that.
In an interview with AFP Claire-Anne Siegrist, one of Switzerland's leading vaccine experts, said that while rushing was understandable for the worst-hit countries, a more cautious approach was reasonable in the Swiss context.
"As of today, this prudence is justified," said the head of the Geneva University Hospital's vaccine division.
"Switzerland is not in the same catastrophic situation as the United States," the country hardest-hit by the pandemic, she said.
Switzerland, a country of some 8.6 million people, has counted 5,000 deaths from the pandemic, and seems to be slowly getting a second wave of infections under control.
Siegrist, dubbed by Swiss media as the "high priestess" of Covid vaccines, said follow-up from large-scale, final-phase human trials of vaccine candidates would take longer in Switzerland.
- 'Additional safety precaution' -
Unlike the United States, the European Union and others, the wealthy Alpine nation does not have a process for emergency authorisations of vaccines or drugs, "even in a pandemic", she explained.
US and European authorities have said they could give emergency approval once they have two months' worth of data following human trials involving tens of thousands of people, to ensure efficiency and safety standards are met, and to detect any unexpected side-effects.
But Swissmedic, the Swiss authority in charge of approving new drugs and vaccines, "requires more data for new vaccines", Siegrist said.
Swiss authorities, she said, will stick to their regular rule of waiting for several additional months, "because surprises could still surface, even rarely, after two months."
"When you have four to five months of follow-up, it is an additional safety precaution."
She acknowledged that the Swiss also hoped to learn from the experiences of countries that begin giving the jabs earlier.
"Having a few months more to accumulate data from the countries that will begin vaccinating earlier and to make sure everything goes smoothly seems reasonable, considering the current situation in Switzerland," she said.
- Vaccine hesitancy -
The 62-year-old vaccine expert said she hoped the more cautious approach, combined with transparency and clarity around the process, would help counter vaccine hesitancy.
She pointed to polls showing that 30 to 50 percent of the Swiss population remain undecided on whether to take a Covid-19 vaccine.
"Their final choice will depend on the quality of the information we can provide them with and the confidence they have in this information," she said.
Issued on: 07/12/2020 - 14:48
Prudence in the Swiss context is justified, says Siegrist Fabrice COFFRINI AFP
4 min
ADVERTISING
Geneva (AFP)
While other countries gear up for rapid roll-outs of Covid-19 vaccines, Switzerland is staking out a slower path, prizing caution over speed, according to a leading vaccine expert.
Britain and Russia will both begin mass vaccination this week, while US and European regulators are expected to provide emergency approval for two vaccines very shortly, with millions of doses set to be given by the end of the year.
But in Switzerland, authorities are in no hurry to approve a vaccine. The first few doses not expected to arrive before late January and larger volumes several months after that.
In an interview with AFP Claire-Anne Siegrist, one of Switzerland's leading vaccine experts, said that while rushing was understandable for the worst-hit countries, a more cautious approach was reasonable in the Swiss context.
"As of today, this prudence is justified," said the head of the Geneva University Hospital's vaccine division.
"Switzerland is not in the same catastrophic situation as the United States," the country hardest-hit by the pandemic, she said.
Switzerland, a country of some 8.6 million people, has counted 5,000 deaths from the pandemic, and seems to be slowly getting a second wave of infections under control.
Siegrist, dubbed by Swiss media as the "high priestess" of Covid vaccines, said follow-up from large-scale, final-phase human trials of vaccine candidates would take longer in Switzerland.
- 'Additional safety precaution' -
Unlike the United States, the European Union and others, the wealthy Alpine nation does not have a process for emergency authorisations of vaccines or drugs, "even in a pandemic", she explained.
US and European authorities have said they could give emergency approval once they have two months' worth of data following human trials involving tens of thousands of people, to ensure efficiency and safety standards are met, and to detect any unexpected side-effects.
But Swissmedic, the Swiss authority in charge of approving new drugs and vaccines, "requires more data for new vaccines", Siegrist said.
Swiss authorities, she said, will stick to their regular rule of waiting for several additional months, "because surprises could still surface, even rarely, after two months."
"When you have four to five months of follow-up, it is an additional safety precaution."
She acknowledged that the Swiss also hoped to learn from the experiences of countries that begin giving the jabs earlier.
"Having a few months more to accumulate data from the countries that will begin vaccinating earlier and to make sure everything goes smoothly seems reasonable, considering the current situation in Switzerland," she said.
- Vaccine hesitancy -
The 62-year-old vaccine expert said she hoped the more cautious approach, combined with transparency and clarity around the process, would help counter vaccine hesitancy.
She pointed to polls showing that 30 to 50 percent of the Swiss population remain undecided on whether to take a Covid-19 vaccine.
"Their final choice will depend on the quality of the information we can provide them with and the confidence they have in this information," she said.
How did you know her maiden name?
It said it on the RTE news